DE3887750D1 - Selektive entfernung von immunkomplexen. - Google Patents

Selektive entfernung von immunkomplexen.

Info

Publication number
DE3887750D1
DE3887750D1 DE89900411T DE3887750T DE3887750D1 DE 3887750 D1 DE3887750 D1 DE 3887750D1 DE 89900411 T DE89900411 T DE 89900411T DE 3887750 T DE3887750 T DE 3887750T DE 3887750 D1 DE3887750 D1 DE 3887750D1
Authority
DE
Germany
Prior art keywords
analogs
bind
complex
protein
immune complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89900411T
Other languages
English (en)
Other versions
DE3887750T2 (de
Inventor
James Huston
Lynn Baird
Charles Cohen
Hermann Opperman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Creative Biomolecules Inc
Original Assignee
Creative Biomolecules Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Biomolecules Inc filed Critical Creative Biomolecules Inc
Application granted granted Critical
Publication of DE3887750D1 publication Critical patent/DE3887750D1/de
Publication of DE3887750T2 publication Critical patent/DE3887750T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
DE3887750T 1987-11-20 1988-10-17 Selektive entfernung von immunkomplexen. Expired - Fee Related DE3887750T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12322487A 1987-11-20 1987-11-20
PCT/US1988/003611 WO1989004675A1 (en) 1987-11-20 1988-10-17 Selective removal of immune complexes

Publications (2)

Publication Number Publication Date
DE3887750D1 true DE3887750D1 (de) 1994-03-24
DE3887750T2 DE3887750T2 (de) 1994-09-15

Family

ID=22407414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887750T Expired - Fee Related DE3887750T2 (de) 1987-11-20 1988-10-17 Selektive entfernung von immunkomplexen.

Country Status (6)

Country Link
EP (1) EP0343227B1 (de)
JP (1) JP2566325B2 (de)
AT (1) ATE101345T1 (de)
AU (1) AU623361B2 (de)
DE (1) DE3887750T2 (de)
WO (1) WO1989004675A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977247A (en) * 1986-02-14 1990-12-11 Genex Corporation Immobilized protein G variants and the use thereof
US5593897A (en) * 1988-04-04 1997-01-14 Northwestern University Binding of immune complexes by modified forms of C-reactive protein
US5364930A (en) * 1990-10-16 1994-11-15 Northwestern University Synthetic C1q peptide fragments
US5932483A (en) * 1990-10-16 1999-08-03 Northwestern University Synthetic peptide and its uses
EP0560807A1 (de) * 1990-11-26 1993-09-22 The Public Health Laboratory Service Board Immunoglobulinbindende proteine und rekombinante dna-molekülen welche dafür codieren
JPH06263795A (ja) * 1992-09-30 1994-09-20 Kuraray Co Ltd ペプチドおよびこれを担体上に固定化してなる吸着剤
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
DE69733467T2 (de) * 1996-01-25 2006-03-23 Kaneka Corp. Adsorbtionsvorrichtung und absorbens für immunuglobine und deren komplexe
WO1998046248A1 (en) 1997-04-14 1998-10-22 Anderson Byron E Method and material for inhibiting complement
GB2362211A (en) * 2000-05-08 2001-11-14 Leuven K U Res & Dev Detecting circulating immune complexes using protein G
DE10036742A1 (de) * 2000-07-27 2002-02-21 Aesku Lab Diagnostika Vorrichtung zur Behandlung von Immunerkrankungen
SE0400274D0 (sv) * 2004-02-09 2004-02-09 Affibody Ab New polypeptide
US20130052209A1 (en) * 2010-04-23 2013-02-28 Purdue Research Foundation Protein drug formulations and packages
BR112017006536A2 (pt) * 2014-09-29 2017-12-19 Fujifilm Corp polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204810L (sv) * 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4687734A (en) * 1984-06-07 1987-08-18 Chester Samuel J Immunoassay for the detection of human colon cancer using a polyclonal antibody derived from a capillary culture of tumor cells
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
EP0293391A4 (de) * 1986-02-14 1989-06-21 Genex Corp Klonierte streptokokkengene, kodierend für protein-g und verwendung zur herstellung rekombinanter mikroorganismen zur erzeugung von protein-g.
SE459662B (sv) * 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants

Also Published As

Publication number Publication date
AU2794389A (en) 1989-06-14
EP0343227B1 (de) 1994-02-09
ATE101345T1 (de) 1994-02-15
DE3887750T2 (de) 1994-09-15
JPH02501985A (ja) 1990-07-05
WO1989004675A1 (en) 1989-06-01
AU623361B2 (en) 1992-05-14
EP0343227A1 (de) 1989-11-29
JP2566325B2 (ja) 1996-12-25

Similar Documents

Publication Publication Date Title
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
RU94024561A (ru) Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка
DK0458841T3 (da) Fremgangsmåde til anvendelse og fremstilling af peptider
WO1992010514A3 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
PT87138A (pt) Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
JPH0662676B2 (ja) 精製されたプロテインｇ
ATE132197T1 (de) Monoklonale antikörper
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
Tamirano et al. Isolation and characterization of secretory IgA (sIgA) and free secretory component (FSC) from rat bile
PT93166A (pt) Metodo para a producao de antigenios de celulas dos ilheus pancreaticos
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
Mason et al. Platelet antigens in chronic idiopathic thrombocytopenic purpura
Sehon et al. Electrophoretic separation of skin-sensitizing antibody from the sera of ragweed-sensitive patients
DE3886109D1 (de) Verfahren zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten und Mittel zu dessen Durchführung.
EP0177814A3 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
SE9002212D0 (sv) Igg binding protein
Kownatzki Studies on a fragment of human IgM macroglobulins related to “J chain”
EP0293827A3 (de) Probe für Leishmaniosis
Abraham Human triclonal anti-IgG gammopathy. I. Iso-electric focusing characteristics of the IgG, IgA and IgM anti-IgG and their heavy and light chains.
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
Matthaeus et al. Identification and behavior of the precipitating BLV antibodies in sera of leukotic cattle
Bornstein et al. A general affinity chromatographic method for preparing monospecific antibody to mammalian serum haptoglobin
Hoag et al. Optimal conditions for isolating human placental alkaline phosphatase by immunosorption
Rogers An improved preparation of murine histocompatibility antigens (H-2b) and a novel membrane binding form of H-2Kb

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee